1-9 of 9
Ezia Bello
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models

Marina Meroni, Ilaria Craparotta, Federica Mirimao, Nicolò Panini, Paolo Ubezio, Ezia Bello, Salvatore Lorenzo Renne, Maurizio D'Incalci, Roberta Frapolli
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7199.
https://doi.org/10.1158/1538-7445.AM2024-7199
Published: 22 March 2024
View article titled, Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models
Journal Articles

Abstract 3764: Trabectedin activity in patient-derived mesothelioma xenografts

Simonetta Andrea Licandro, Roberta Frapolli, Ezia Bello, Roberta Libener, Sara Orecchia, Federica Grosso, Maurizio D’Incalci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3764.
https://doi.org/10.1158/1538-7445.AM2016-3764
Published: 15 July 2016
View article titled, Abstract 3764: Trabectedin activity in patient-derived mesothelioma xenografts
Journal Articles

Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models

Paola Allavena, Cristina Belgiovine, Manuela Liguori, Ezia Bello, Roberta Frapolli, Carlos M. Galmarini, Maurizio D’Incalci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1284.
https://doi.org/10.1158/1538-7445.AM2016-1284
Published: 15 July 2016
View article titled, Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models
Journal Articles

Abstract 1183: PPARgamma agonist promotes adipocytic differentiation and potentiates the activity of trabectedin in myxoid liposarcoma

Ezia Bello, Roberta Frapolli, Simonetta Andrea Licandro, Silvia Brich, Laura Carrassa, Roberta Sanfilippo, Alessandro Gronchi, Paolo Casali, Silvana Pilotti, Maurizio D’Incalci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1183.
https://doi.org/10.1158/1538-7445.AM2016-1183
Published: 15 July 2016
View article titled, Abstract 1183: PPARgamma agonist promotes adipocytic differentiation and potentiates the activity of trabectedin in myxoid liposarcoma
Journal Articles

Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models

Ezia Bello, Rosaria Chilà, Federica Guffanti, Monique Zangarini, Laura Ceriani, Massimo Zucchetti, Saba Chaudi, Marie-Jeanne Pierrat, Anne Jacquet-Bescond, Giovanna L.M. Damia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2670.
https://doi.org/10.1158/1538-7445.AM2014-2670
Published: 01 October 2014
View article titled, Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
Journal Articles

Abstract 2574: Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231

Giovanna Damia, Ezia Bello, Gennaro Colella, Alexander Berndt, Maurizio D'Incalci, Ennio Cavalletti, Gabriella Camboni
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2574.
https://doi.org/10.1158/1538-7445.AM2011-2574
Published: 15 April 2011
View article titled, Abstract 2574: Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231
Journal Articles

E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models

Ezia Bello, Gennaro Colella, Valentina Scarlato, Paolo Oliva, Alexander Berndt, Giovanni Valbusa, Sonia Colombo Serra, Maurizio D'Incalci, Ennio Cavalletti, Raffaella Giavazzi, Giovanna Damia, Gabriella Camboni
Journal: Cancer Research
Cancer Res (2011) 71 (4): 1396–1405.
https://doi.org/10.1158/0008-5472.CAN-10-2700
Published: 14 February 2011
View article titled, E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
Open the PDF for E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models in another window
Includes: Supplementary data
Journal Articles

The effect of vandetanib on tumor vasculature remodeling and paclitaxel uptake in a xenograft model of ovarian carcinoma

Marta Cesca, Roberta Frapolli, Ezia Bello, Alexander Berndt, Petra Richter, Anderson Ryan, Raffella Giavazzi
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4762.
Published: 01 May 2008
View article titled, The effect of vandetanib on tumor vasculature remodeling and paclitaxel uptake in a xenograft model of ovarian carcinoma
Journal Articles

Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring

Giovanni L. Beretta, Giovanna Petrangolini, Michelandrea De Cesare, Graziella Pratesi, Paola Perego, Stella Tinelli, Monica Tortoreto, Massimo Zucchetti, Roberta Frapolli, Ezia Bello, Carla Manzotti, Gabriele Fontana, Ezio Bombardelli, Arturo Battaglia, Cristian Samorì, Franco Zunino
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10976–10982.
https://doi.org/10.1158/0008-5472.CAN-06-2158
Published: 15 November 2006
View article titled, Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring
Open the PDF for Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring in another window